Pintuition Validated as a Safe and Reliable Navigation Solution by Large Real-World Data from the iBRA-NET study
Eindhoven, Netherlands – 20 May 2025 – Sirius Medical proudly announces positive results from the...
Posts by Sirius Medical:
Sirius Medical announces new Director Clinical & Medical Affairs
Sirius Medical, a medical device company that provides surgical navigation for non-palpable tumor...
Sirius Medical and Mammotome Partner to Distribute Sirius Pintuition® Across the United States and Germany
Cincinnati, Ohio, US and Eindhoven, Netherlands – February 27, 2025 - Sirius Medical, the...
Sirius Medical Secures Scale-Up Funding to Further Advance its Surgical Marker Navigation portfolio and Expand its Global Presence
Eindhoven, the Netherlands – 4 February 2025 – As World Cancer Day is observed, Dutch medical...
Elisabeth TweeSteden Hospital Reaches Milestone with 1000th Pintuition-Guided Breast-Conserving Surgery
Eindhoven, Netherlands – 8 October 2024 – The Elisabeth-TweeSteden Hospital (ETZ) in the...
Sirius Medical Launches Pintuition Slim Probe in Europe at ESSO43
Eindhoven, Netherlands – 30 September 2024 – Sirius Medical, the leader in surgical marker...
Sirius Medical Announces Collaboration with Medteq to Launch Sirius Pintuition in Greece and Cyprus
Eindhoven, 9 April 2024 — Sirius Medical, the leading innovator in Surgical Marker Navigation, is...
Sirius Medical Celebrates the Enrollment of the First Patient in the MELODY Study with Pintuition®
Eindhoven, Netherlands – January 24, 2023 – Sirius Medical is proud to celebrate the enrollment...
Sirius Medical Ranked Most Innovative Dutch Healthcare SME by the Chamber of Commerce, Third Overall
Eindhoven, Netherlands – December 1, 2023 – Sirius Medical, a leader in Surgical Marker...
FDA Clears Sirius Pintuition® for Long-term and Soft Tissue Implantation
Eindhoven, Netherlands – November 14, 2023 – In a ground-breaking development, Sirius Medical,...